Crossmark Steward Global Equity Income Fund Class C (SGIFX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
35.09
+0.06 (0.17%)
Apr 25, 2025, 4:00 PM EDT
3.21% (1Y)
Fund Assets | 365.34M |
Expense Ratio | 2.03% |
Min. Investment | $1,000 |
Turnover | n/a |
Dividend (ttm) | 1.40 |
Dividend Yield | 3.98% |
Dividend Growth | n/a |
Payout Frequency | Quarterly |
Ex-Dividend Date | Mar 14, 2025 |
Previous Close | 35.03 |
YTD Return | 1.24% |
1-Year Return | 7.34% |
5-Year Return | 73.95% |
52-Week Low | n/a |
52-Week High | n/a |
Beta (5Y) | n/a |
Holdings | 88 |
Inception Date | Dec 13, 2017 |
About SGIFX
The Crossmark Steward Global Equity Income Fund Class C (SGIFX) seeks to have 30% to 50% of its net assets, and, under normal market conditions, no less than 30% of its net assets, invested in securities of non-US issuers.
Category World Large-Stock Value
Performance Rating Below Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol SGIFX
Share Class Class C
Index S&P Global 1200 TR
Performance
SGIFX had a total return of 7.34% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.55%.
Top 10 Holdings
23.08% of assetsName | Symbol | Weight |
---|---|---|
The Cigna Group | CI | 2.73% |
Taiwan Semiconductor Manufacturing Company Limited | TSM | 2.67% |
McDonald's Corporation | MCD | 2.65% |
NatWest Group plc | NWG | 2.37% |
International Business Machines Corporation | IBM | 2.29% |
Paychex, Inc. | PAYX | 2.17% |
The Gap, Inc. | GAP | 2.15% |
Abbott Laboratories | ABT | 2.11% |
Gilead Sciences, Inc. | GILD | 2.02% |
Lloyds Banking Group plc | LYG | 1.92% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Mar 14, 2025 | $0.01969 | Mar 17, 2025 |
Dec 19, 2024 | $1.04344 | Dec 19, 2024 |
Sep 20, 2024 | $0.22171 | Sep 23, 2024 |
Jun 14, 2024 | $0.11187 | Jun 17, 2024 |
Dec 21, 2023 | $0.28427 | Dec 21, 2023 |
Sep 15, 2023 | $0.1567 | Sep 15, 2023 |